The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence-Reference-Cited by-同舟云学术

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence

Published:2020-09 Issue: Volume:274 Page:903-910
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

McIntyre Roger S,Rodrigues Nelson B,Lee Yena,Lipsitz Orly,Subramaniapillai Mehala,Gill Hartej,Nasri Flora,Majeed Amna,Lui Leanna M W,Senyk Olena,Phan Lee,Carvalho Isabelle P.,Siegel Ashley,Mansur Rodrigo B.,Brietzke Elisa,Kratiuk Kevin,Arekapudi Anil K.,Abrishami Amir,Chau Edmond H.,Szpejda Witold,Rosenblat Joshua D.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference41 articles.

1. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression;Acevedo-Diaz;J. Affect. Disord,2019

2. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatry,2000

3. Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS);Bremner;J. Traum. Stress,1998

4. The use of ketamine as an antidepressant: a systematic review and meta-analysis;Coyle;Hum. Psychopharmacol.,2015

5. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: a Randomized Clinical Trial;Daly;JAMA Psychiatry,2019

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder;Pharmacological Reports;2024-08-26

2. Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression;Translational Psychiatry;2024-08-06

3. The Quest for Optimal Ketamine Dosing Formula in Treatment-Resistant Major Depressive Disorder;2024-07-12

4. Comment on: “Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial”;Psychiatry Research;2024-07

5. Efficacy of intravenous esketamine in reducing suicidal ideation and major depressive symptoms: A real-world evidence study;Journal of Affective Disorders Reports;2024-07